Jack Daniel's parent Brown-Forman stock gains after sales top expectations, amid strength in premium bourbons and RTDs
Shares of Jack Daniel's-parent Brown-Forman Corp. (BFA) edged up 0.3% in premarket trading Wednesday, after the spirits company reported fiscal fourth-quarter profit that matched expectations while sales rose above forecasts, amid strength in premium bourbons and the ready-to-drink category. Net income for the quarter to April 30 rose to $207 million, or 43 cents a share, from $151 million, or 31 cents a share, in the year-ago period. The FactSet consensus for earnings per share was 43 cents. Sales grew 5.0% to $1.05 billion, above the FactSet consensus of $990.4 million. For fiscal 2023, sales for the Jack Daniel's family of brands rose 4%, including 11% growth in ready-to-drink (RTD)/ready-to-pour (RTP) sales, while premium bourbon sales increased 23% and tequila sales increased 10%. "Ready-to-Drinks (RTDs) growth continued to be driven by consumer preference for convenience and flavor," the company said in a statement. For fiscal 2024, the company said it believes "trends will normalize" after two-straight years of double-digit organic sales growth. The stock has slipped 5.2% year to date through Tuesday, while the S&P 500 has gained 11.6%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-07-23 0839ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Capital Allocation
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?